← Leaderboards
Emily Bernstein
Icahn School Of Medicine At Mount Sinai
$7,701,150
Attributed
$8,740,579
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,740,579 · 6
By mechanism
R01$8,000,794 · 3
R21$403,599 · 1
P01$307,680 · 1
P30$28,506 · 1
Top collaborators
- Julio A Aguirre-Ghiso5 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Gang Fang$15,326,479
- Michael Rendl$16,676,175
- Oscar L Rodriguez$85,060
- Dan Filipescu$169,000
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMalignant NeoplasmsEpigenetic ProcessProgramsChromatinIn VitroIn VivoNeoplasm MetastasisGenesChip-SeqVariantMediatingHistonesTumorRegulationTranscriptome SequencingBaseMigrationReportingGenomeBiologyGene ExpressionCell LineProteins
Grant awards (24)
Epigenomics of Mutant p53$307,680
P01 · FY2025 · CA · contact PI
Cancer Mechanisms$28,506
P30 · FY2025 · CA · contact PI
Mechanisms and Modeling of Neuroblastoma-Associated ATRX Alterations$388,937
R01 · FY2024 · NS · contact PI
Mechanisms and Modeling of Neuroblastoma-Associated ATRX Alterations$400,966
R01 · FY2023 · NS · contact PI
Mechanisms and modeling of neuroblastoma-associated ATRX alterations$400,966
R01 · FY2022 · NS · contact PI
Deciphering the tumor suppressive functions of macroH2A$448,328
R01 · FY2021 · CA · contact PI
Mechanisms and modeling of neuroblastoma-associated ATRX alterations$400,966
R01 · FY2021 · NS · contact PI
Epigenetic and microenvironmental regulation of dormant disseminated cancer$277,249
R01 · FY2021 · CA
Deciphering the tumor suppressive functions of macroH2A$448,328
R01 · FY2020 · CA · contact PI
Epigenetic and microenvironmental regulation of dormant disseminated cancer$428,136
R01 · FY2020 · CA
Mechanisms and modeling of neuroblastoma-associated ATRX alterations$417,299
R01 · FY2020 · NS · contact PI
Epigenetic and microenvironmental regulation of dormant disseminated cancer$499,826
R01 · FY2019 · CA
Deciphering the tumor suppressive functions of macroH2A$423,368
R01 · FY2019 · CA · contact PI
Deciphering the tumor suppressive functions of macroH2A$436,463
R01 · FY2018 · CA · contact PI
Epigenetic and microenvironmental regulation of dormant disseminated cancer$428,136
R01 · FY2018 · CA
Epigenetic and microenvironmental regulation of dormant disseminated cancer$445,511
R01 · FY2017 · CA
Deciphering the tumor suppressive functions of macroH2A$439,563
R01 · FY2017 · CA · contact PI
Deciphering macroH2A function in melanoma progression$349,644
R01 · FY2015 · CA · contact PI
Deciphering macroH2A function in melanoma progression$339,155
R01 · FY2014 · CA · contact PI
Deciphering macroH2A function in melanoma progression$328,665
R01 · FY2013 · CA · contact PI
Deciphering macroH2A function in melanoma progression$349,644
R01 · FY2012 · CA · contact PI
Deciphering macroH2A function in melanoma progression$349,644
R01 · FY2011 · CA · contact PI
Epigenetic Biomarker Discovery in Cutaneous Neoplasms$216,879
R21 · FY2011 · CA · contact PI
Epigenetic Biomarker Discovery in Cutaneous Neoplasms$186,720
R21 · FY2010 · CA · contact PI